# Extracorporeal membrane oxygenation circuit

Technology · id `cardio:extracorporeal-membrane-oxygenation-circuit` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: ECMO circuit; Extracorporeal circuit and accessories for long-term respiratory/cardiopulmonary failure

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

An ECMO circuit is the equipment set that carries blood out of the body, adds oxygen and returns it. MeSH says the system may consist of a pump, a membrane oxygenator and a heat exchanger. In the United States, FDA classes extracorporeal circuits and accessories for long-term respiratory or cardiopulmonary failure as class 2 devices under one product code. This page records that classification and one clearance as examples; it records no study of benefit or harm.

## Technical summary

MeSH descriptor D015199 is a broad match: it names the procedure, not the equipment. FDA product code QJZ (Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure), regulation number 870.4100, class 2, is also a broad match, because the classification record does not use the word ECMO. Clearance K240880 (VitalFlow Set with Balance Biosurface, Medtronic, Substantially Equivalent, 2024-09-12) is read as an example; the other three clearances under the code were not read.

## Claims, with the population each applies to

## Context: Extracorporeal circuits and accessories as classified by the US FDA under product code QJZ

Recipient: No clinical recipient; Population: Not applicable: the classification record describes a device type, not a patient group.; Care setting: Not stated in the classification record; Geography: United States (device classification of the US Food and Drug Administration); Life stage: Not applicable; Follow-up: Not applicable (regulatory classification)

### The openFDA device classification for product code QJZ names the device type extracorporeal system for long-term respiratory or cardiopulmonary failure, defined as an extracorporeal circuit and accessories for long-term respiratory or cardiopulmonary failure. It places the type in class 2 under regulation number 870.4100. One 510(k) clearance under this code, K240880 (VitalFlow Set with Balance Biosurface, Medtronic), has the decision Substantially Equivalent dated 12 September 2024.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: No clinical recipient; Population: Not applicable: the classification record describes a device type, not a patient group.; Care setting: Not stated in the classification record; Geography: United States (device classification of the US Food and Drug Administration); Life stage: Not applicable; Follow-up: Not applicable (regulatory classification)
- Limitations: This is a regulatory classification, not a finding about benefit or safety. The classification record does not use the word ECMO or name a heart condition. Only one of the four clearances listed under the code is read. openFDA says its data are unvalidated and not to be relied on for decisions about medical care.
- Last checked: 2026-11-08
- Sources:
  1. Supports: openFDA device classification, product code QJZ (Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure) (Regulator, edition The openFDA device classification record returned on 2026-11-08 for product code QJZ.) <https://api.fda.gov/device/classification.json?search=product_code:QJZ>
     Locator: results\[0\].product\_code. Retrieved 2026-11-08T20:41:32Z. Source state: Current. Version fingerprint: f26d3ed35da752dce79f7aac534e28e6671391f379429c9a96cb77b37eaf21c0.
     How it applies: Quoted at this locator.
  2. Supports: openFDA device classification, product code QJZ (Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure) (Regulator, edition The openFDA device classification record returned on 2026-11-08 for product code QJZ.) <https://api.fda.gov/device/classification.json?search=product_code:QJZ>
     Locator: results\[0\].device\_name. Retrieved 2026-11-08T20:41:32Z. Source state: Current. Version fingerprint: f26d3ed35da752dce79f7aac534e28e6671391f379429c9a96cb77b37eaf21c0.
     How it applies: Quoted at this locator.
  3. Supports: openFDA device classification, product code QJZ (Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure) (Regulator, edition The openFDA device classification record returned on 2026-11-08 for product code QJZ.) <https://api.fda.gov/device/classification.json?search=product_code:QJZ>
     Locator: results\[0\].definition. Retrieved 2026-11-08T20:41:32Z. Source state: Current. Version fingerprint: f26d3ed35da752dce79f7aac534e28e6671391f379429c9a96cb77b37eaf21c0.
     How it applies: Quoted at this locator.
  4. Supports: openFDA device classification, product code QJZ (Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure) (Regulator, edition The openFDA device classification record returned on 2026-11-08 for product code QJZ.) <https://api.fda.gov/device/classification.json?search=product_code:QJZ>
     Locator: results\[0\].device\_class. Retrieved 2026-11-08T20:41:32Z. Source state: Current. Version fingerprint: f26d3ed35da752dce79f7aac534e28e6671391f379429c9a96cb77b37eaf21c0.
     How it applies: Quoted at this locator.
  5. Supports: openFDA device classification, product code QJZ (Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure) (Regulator, edition The openFDA device classification record returned on 2026-11-08 for product code QJZ.) <https://api.fda.gov/device/classification.json?search=product_code:QJZ>
     Locator: results\[0\].regulation\_number. Retrieved 2026-11-08T20:41:32Z. Source state: Current. Version fingerprint: f26d3ed35da752dce79f7aac534e28e6671391f379429c9a96cb77b37eaf21c0.
     How it applies: Quoted at this locator.
  6. Supports: FDA 510(k) premarket notification K240880: VitalFlow Set with Balance Biosurface (openFDA record) (Regulator, edition The openFDA 510(k) endpoint record, from a dataset last updated 2026-10-26.) <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K240880>
     Locator: results\[0\].device\_name. Retrieved 2026-11-08T20:42:21Z. Source state: Current. Version fingerprint: c050c9e820240712004e5d3f0fe11fb99e9a7a1c8b75475099fc8f7cb91debed.
     How it applies: Quoted at this locator.
  7. Supports: FDA 510(k) premarket notification K240880: VitalFlow Set with Balance Biosurface (openFDA record) (Regulator, edition The openFDA 510(k) endpoint record, from a dataset last updated 2026-10-26.) <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K240880>
     Locator: results\[0\].applicant. Retrieved 2026-11-08T20:42:21Z. Source state: Current. Version fingerprint: c050c9e820240712004e5d3f0fe11fb99e9a7a1c8b75475099fc8f7cb91debed.
     How it applies: Quoted at this locator.
  8. Supports: FDA 510(k) premarket notification K240880: VitalFlow Set with Balance Biosurface (openFDA record) (Regulator, edition The openFDA 510(k) endpoint record, from a dataset last updated 2026-10-26.) <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K240880>
     Locator: results\[0\].product\_code. Retrieved 2026-11-08T20:42:21Z. Source state: Current. Version fingerprint: c050c9e820240712004e5d3f0fe11fb99e9a7a1c8b75475099fc8f7cb91debed.
     How it applies: Quoted at this locator.
  9. Supports: FDA 510(k) premarket notification K240880: VitalFlow Set with Balance Biosurface (openFDA record) (Regulator, edition The openFDA 510(k) endpoint record, from a dataset last updated 2026-10-26.) <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K240880>
     Locator: results\[0\].decision\_date. Retrieved 2026-11-08T20:42:21Z. Source state: Current. Version fingerprint: c050c9e820240712004e5d3f0fe11fb99e9a7a1c8b75475099fc8f7cb91debed.
     How it applies: Quoted at this locator.
  10. Supports: FDA 510(k) premarket notification K240880: VitalFlow Set with Balance Biosurface (openFDA record) (Regulator, edition The openFDA 510(k) endpoint record, from a dataset last updated 2026-10-26.) <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K240880>
     Locator: results\[0\].decision\_description. Retrieved 2026-11-08T20:42:21Z. Source state: Current. Version fingerprint: c050c9e820240712004e5d3f0fe11fb99e9a7a1c8b75475099fc8f7cb91debed.
     How it applies: Quoted at this locator.

## Connected pages

- The temporary-support page lists venoarterial ECMO among temporary supports: Temporary mechanical circulatory support (heart pumps) (`cardio:mechanical-circulatory-support`)
- Filed under this front: Devices and monitoring (`cardio:front-devices-and-monitoring`)
- Used by: Extracorporeal membrane oxygenation (ECMO) (`cardio:extracorporeal-membrane-oxygenation-ecmo`)

## Provenance

Content hash: 3d2049b98f717f4376297abc78a0e3747dd9bea1d9ebc9fb1dca21345f366a89
Last substantive edit: 2026-11-08
Evidence last checked: 2026-11-08
